Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 37784465
Efficacy and Safety Results of the Afatinib Expanded Access Program.
Kim ES, Halmos B, Kohut IF, Patel T, Rostorfer RD, Spira AI, Cseh A, McKay J, Wallenstein G, Mileham KF. Kim ES, et al. Among authors: mileham kf. Oncol Ther. 2017;5(1):103-110. doi: 10.1007/s40487-017-0043-5. Epub 2017 Apr 10. Oncol Ther. 2017. PMID: 28680960 Free PMC article.
Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report.
Thummalapalli R, Choudhury NJ, Ehrich F, Beardslee T, Brazel D, Zhang SS, Merchant S, Chen MF, Heller G, Ramalingam SS, Ou SI, Mileham KF, Riely GJ. Thummalapalli R, et al. Among authors: mileham kf. JTO Clin Res Rep. 2023 Jun 30;4(8):100546. doi: 10.1016/j.jtocrr.2023.100546. eCollection 2023 Aug. JTO Clin Res Rep. 2023. PMID: 37644967 Free PMC article.
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont Study.
Eisner JR, Mayhew GM, Davison JM, Beebe KD, Shibata Y, Guo Y, Farhangfar C, Farhangfar F, Uronis JM, Conroy JM, Milburn MV, Hayes DN, Mileham KF. Eisner JR, et al. Among authors: mileham kf. Clin Cancer Res. 2023 Aug 15;29(16):3203-3213. doi: 10.1158/1078-0432.CCR-22-2558. Clin Cancer Res. 2023. PMID: 37233991 Free PMC article.
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients.
Farhangfar CJ, Scarola GT, Morris VA, Farhangfar F, Dumas K, Symanowski J, Hwang JJ, Mileham KF, Carrizosa DR, Naumann RW, Livasy C, Kim ES, Raghavan D. Farhangfar CJ, et al. Among authors: mileham kf. JCO Clin Cancer Inform. 2022 Jul;6:e2200011. doi: 10.1200/CCI.22.00011. JCO Clin Cancer Inform. 2022. PMID: 35839431 Free article.
32 results